Serial Number 88171100
Registration 5823425
702

Registration Progress

Application Filed
Oct 26, 2018
Under Examination
May 21, 2019
Approved for Publication
Mar 26, 2019
Published for Opposition
Mar 26, 2019
Registered
Jul 30, 2019

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20190730) (Grace Period Filing)
Due: Jan 30, 2026 Grace Period - 9 days
Original deadline was Jul 30, 2025 (overdue)

Trademark Image

Basic Information

Serial Number
88171100
Registration Number
5823425
Filing Date
October 26, 2018
Registration Date
July 30, 2019
Published for Opposition
March 26, 2019
Drawing Code
2

Status Summary

Current Status
Active
Status Code
702
Status Date
Nov 20, 2025
Registration
Registered
Classes
005

Rights Holder

AbbVie Biotechnology Ltd

03
Address
Clarendon House
2 Church Street
Hamilton HM11
BM

Ownership History

AbbVie Biotechnology Ltd

Original Applicant
03
Hamilton BM

AbbVie Biotechnology Ltd

Owner at Publication
03
Hamilton BM

AbbVie Biotechnology Ltd

Original Registrant
03
Hamilton BM

Legal Representation

Attorney
Sonali S. Srivastava

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 Declaration Due (Principal Register) (Based on registration date 20190730)
Due Date
July 30, 2025
Grace Period Ends
January 30, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Nov 20, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Nov 20, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Nov 17, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jul 30, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jul 30, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jul 30, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 22, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 21, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jun 6, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 21, 2019 IUAF S USE AMENDMENT FILED Loading...
Jun 3, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 21, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
May 21, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 26, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 26, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 6, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 11, 2019 ALIE A ASSIGNED TO LIE Loading...
Jan 25, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 25, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 25, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 25, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 25, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 22, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 10, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 9, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 30, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Anywhere: Apr 23, 2019
First Use in Commerce: Apr 23, 2019

Additional Information

Design Mark
The mark consists of an interlocking wave design with a series of 2 blue waves on the left and 3 waves on the right, one blue, one purple and one plum. There is gray shadowing on the inside of the waves and the entire design resembles an infinity symbol.
Color Claim
The colors blue, purple, plum, and gray are claimed as a feature of the mark.

Classification

International Classes
005